Subthalamic NucleusCorpus StriatumDeep Brain StimulationNucleus AccumbensParkinson DiseaseGlobus PallidusDopamine3,4-Dihydroxyphenylacetic AcidSubstantia NigraBasal GangliaSubthalamusBrainAntiparkinson AgentsReceptors, DopamineThalamic NucleiLevodopaElectrodes, ImplantedBeta RhythmNeuronsStereotaxic TechniquesRats, Sprague-DawleyBerberineCorpus LuteumHypokinesiaElectric Stimulation TherapyCorpus CallosumOxidopamineDyskinesiasCell NucleusNeural PathwaysRats, Inbred StrainsParkinsonian DisordersEntopeduncular NucleusDyskinesia, Drug-InducedAgenesis of Corpus CallosumDopamine AgentsBehavior, AnimalMotor ActivityDopamine AntagonistsThalamusAction PotentialsMagnetic Resonance ImagingElectric StimulationApomorphineMicroelectrodesTremorMuscle RigidityCocaineNeostriatumCaudate NucleusDopamine AgonistsBiological ClocksReaction TimeBrain MappingRewardFunctional LateralityReceptors, Dopamine D2MicroinjectionsDopamine Uptake InhibitorsAnalysis of VarianceConditioning, OperantMicrodialysisStereotyped BehaviorParkinson Disease, SecondarySynaptic TransmissionNeuropsychological TestsMuscimolInhibition (Psychology)Neural InhibitionMovementCuesPedunculopontine Tegmental NucleusMotor SkillsRats, WistarDysarthriaSeptal NucleiMedial Forebrain BundleAmphetamineImage Processing, Computer-Assisted1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinePsychomotor PerformanceContingent Negative VariationCerebral Cortexgamma-Aminobutyric AcidSelf AdministrationPrefrontal CortexReceptors, Dopamine D1Models, NeurologicalPseudobulbar PalsySensation DisordersSpeech DisordersGABA AntagonistsVentral Thalamic NucleiTime FactorsMesencephalonProto-Oncogene Proteins c-fosRats, Long-EvansMotor CortexElectroencephalographyExcitatory Amino Acid Antagonists